1Ayuso-Mateos, JL, Vazquez-Barquero, JL, Dowrick, C, Lehtinen, V, Dalgard, OS, Casey, P, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. B J Psychiatry 2001; 179: 308–16.
2Flint, J, Kendler, KS. The genetics of major depression. Neuron 2014; 81: 484–503.
3Hyde, CL, Nagle, MW, Tian, C, Chen, X, Paciga, SA, Wendland, JR, et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet 2016; 48: 1031–6.
4CONVERGE consortium. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 2015; 523: 588–91.
5Vaquero, A, Sternglanz, R, Reinberg, D. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 2007; 26: 5505–20.
6Kishi, T, Yoshimura, R, Kitajima, T, Okochi, T, Okumura, T, Tsunoka, T, et al. SIRT1 gene is associated with major depressive disorder in the Japanese population. J Affect Disord 2010; 126: 167–73.
7Luo, XJ, Zhang, C. Down-regulation of SIRT1 gene expression in major depressive Disorder. Am J Psychiatry 2016; 173: 1046.
8Abe-Higuchi, N, Uchida, S, Yamagata, H, Higuchi, F, Hobara, T, Hara, K, et al. Hippocampal sirtuin 1 signaling mediates depression-like behavior. Biol Psychiatry 2016; 80: 815–26.
9Kim, HD, Hesterman, J, Call, T, Magazu, S, Keeley, E, Armenta, K, et al. SIRT1 Mediates depression-like behaviors in the nucleus accumbens. J Neurosci 2016; 36: 8441–52.
10Kodali, M, Parihar, VK, Hattiangady, B, Mishra, V, Shuai, B, Shetty, AK. Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation. Sci Rep 2015; 5: 8075.
11Ashburner, J, Friston, KJ. Unified segmentation. Neuroimage 2005; 26: 839–51.
12Friston, KJ, Ashburner, J, Frith, CD, Poline, JB, Heather, JD, Frackowiak, RSJ. Spatial registration and normalization of images. Hum Brain Mapp 1995; 3: 165–89.
13Sui, J, Pearlson, GD, Du, Y, Yu, Q, Jones, TR, Chen, J, et al. In search of multimodal neuroimaging biomarkers of cognitive deficits in schizophrenia. Biol Psychiatry 2015; 78: 794–804.
14Anderson, CA, Pettersson, FH, Clarke, GM, Cardon, LR, Morris, AP, Zondervan, KT. Data quality control in genetic case-control association studies. Nat Protoc 2010; 5: 1564–73.
15Purcell, S, Neale, B, Todd-Brown, K, Thomas, L, Ferreira, MA, Bender, D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–75.
16Genovese, CR, Lazar, NA, Nichols, T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870–8.
17Cox, RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996; 29: 162–73.
181000 Genomes Project Consortium, Abecasis, GR, Auton, A, Brooks, LD, DePristo, MA, Durbin, RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56–65.
19Pruim, RJ, Welch, RP, Sanna, S, Teslovich, TM, Chines, PS, Gliedt, TP, et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010; 26: 2336–7.
20Chang, H, Hoshina, N, Zhang, C, Ma, Y, Cao, H, Wang, Y, et al. The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders. Mol Psychiatry 2018; 23: 400–12.
21Li, M, Luo, XJ, Rietschel, M, Lewis, CM, Mattheisen, M, Muller-Myhsok, B, et al. Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility. Mol Psychiatry 2014; 19: 452–61.
22Giedd, JN, Rapoport, JL. Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron 2010; 67: 728–34.
23Schmaal, L, Veltman, DJ, van Erp, TG, Samann, PG, Frodl, T, Jahanshad, N, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry 2016; 21: 806–12.
24Schmaal, L, Hibar, DP, Samann, PG, Hall, GB, Baune, BT, Jahanshad, N, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry 2017; 22: 900–9.
25Hibar, DP, Stein, JL, Renteria, ME, Arias-Vasquez, A, Desrivieres, S, Jahanshad, N, et al. Common genetic variants influence human subcortical brain structures. Nature 2015; 520: 224–9.
26Lippard, ETC, Jensen, KP, Wang, F, Johnston, JAY, Spencer, L, Pittman, B, et al. Effects of ANK3 variation on gray and white matter in bipolar disorder. Mol Psychiatry 2017; 22: 1345–51.
27Bora, E, Fornito, A, Pantelis, C, Yucel, M. Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord 2012; 138: 9–18.
28Konarski, JZ, McIntyre, RS, Kennedy, SH, Rafi-Tari, S, Soczynska, JK, Ketter, TA. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord 2008; 10: 1–37.
29Truong, W, Minuzzi, L, Soares, CN, Frey, BN, Evans, AC, MacQueen, GM, et al. Changes in cortical thickness across the lifespan in major depressive disorder. Psychiatry Res 2013; 214: 204–11.
30Kempton, MJ, Salvador, Z, Munafo, MR, Geddes, JR, Simmons, A, Frangou, S, et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry 2011; 68: 675–90.
31Liakakis, G, Nickel, J, Seitz, RJ. Diversity of the inferior frontal gyrus--a meta-analysis of neuroimaging studies. Behav Brain Res 2011; 225: 341–7.
32Mason, RA, Just, MA. Differentiable cortical networks for inferences concerning people's intentions versus physical causality. Hum Brain Mapp 2011; 32: 313–29.